334 related articles for article (PubMed ID: 37657881)
1. Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease.
Sharma P; Sawtell R; Wang Q; Sise ME
Adv Kidney Dis Health; 2023 Jul; 30(4):343-355. PubMed ID: 37657881
[TBL] [Abstract][Full Text] [Related]
2. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
Vallet-Pichard A; Pol S
Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
Cacoub P; Desbois AC; Isnard-Bagnis C; Rocatello D; Ferri C
J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
[TBL] [Abstract][Full Text] [Related]
4. Liver Disease-Associated Glomerulopathies.
Kanduri SR; Peleg Y; Wadhwani S
Adv Kidney Dis Health; 2024 Mar; 31(2):147-156. PubMed ID: 38649219
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus associated glomerulopathies.
Ozkok A; Yildiz A
World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
Rutledge SM; Chung RT; Sise ME
Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
[TBL] [Abstract][Full Text] [Related]
7. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
[TBL] [Abstract][Full Text] [Related]
8. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
[TBL] [Abstract][Full Text] [Related]
9. Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease.
Strohbehn IA; Seethapathy R; Lee M; Sise ME
Kidney360; 2021 Aug; 2(8):1316-1325. PubMed ID: 35369667
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up.
Fabrizi F; Aghemo A; Lampertico P; Fraquelli M; Cresseri D; Moroni G; Passerini P; Donato FM; Messa P
Int J Artif Organs; 2018 Jun; 41(6):306-318. PubMed ID: 29595085
[TBL] [Abstract][Full Text] [Related]
11. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.
Mendizabal M; Reddy KR
J Viral Hepat; 2017 Jun; 24(6):442-453. PubMed ID: 28107583
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
Bersoff-Matcha SJ; Cao K; Jason M; Ajao A; Jones SC; Meyer T; Brinker A
Ann Intern Med; 2017 Jun; 166(11):792-798. PubMed ID: 28437794
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline.
Awan AA; Jadoul M; Martin P
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2158-2167. PubMed ID: 31376491
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
[TBL] [Abstract][Full Text] [Related]
16. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.
Lee JJ; Lin MY; Yang YH; Lu SN; Chen HC; Hwang SJ
Am J Kidney Dis; 2010 Jul; 56(1):23-31. PubMed ID: 20400217
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy.
Kawagishi N; Suda G; Sakamori R; Matsui T; Onozawa M; Yang Z; Yoshida S; Ohara M; Kimura M; Kubo A; Maehara O; Fu Q; Hosoda S; Tokuchi Y; Suzuki K; Nakai M; Sho T; Morikawa K; Natsuizaka M; Ogawa K; Sakai H; Ohnishi S; Baba M; Takehara T; Sakamoto N
Sci Rep; 2022 Oct; 12(1):16800. PubMed ID: 36207368
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatitis C-related kidney disease.
Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in "special populations".
Pol S; Parlati L
Liver Int; 2018 Feb; 38 Suppl 1():28-33. PubMed ID: 29427485
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
